| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.15 | 0.002 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | 0.11 | 0.01 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.096 | 0.03 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | 0.11 | 0.04 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.073 | 0.1 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | -0.066 | 0.1 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | 0.075 | 0.1 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.068 | 0.1 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.063 | 0.2 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.056 | 0.2 |